RxDoctor Payments Data

Barnwell Myers, MD

Psychiatry · Greenville, SCNPI 1891746830

Payments from drug & device makers

$724in general payments, 2019–2025

Across 51 payments — averaging $14.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$399
  • Lundbeck LLC$84
  • Johnson & Johnson$69
  • Takeda Pharmaceuticals U.S.A., Inc.$50
  • Supernus Pharmaceuticals, Inc.$42
  • Otsuka America Pharmaceutical, Inc.$28
  • plus $52 from 2 others

What the payments were for

  • Food & beverage$724100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$724 in reported general payments places this provider in the 60th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$48,719
Medicare patients
146
Services billed
409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine849$29,262
Lurasidone Hcl41$22,092
Alprazolam1,720$13,068
VyvanseLisdexamfetamine Dimesylate21$12,272
Modafinil53$10,465
Aripiprazole173$9,150
Trazodone Hcl734$7,333
Duloxetine Hcl301$6,418
Bupropion XlBupropion Hcl335$5,818
Lamotrigine310$5,046
Olanzapine198$3,687
Quetiapine Fumarate274$3,229
Asenapine Maleate22$3,197
Triazolam43$3,063
Clonazepam455$3,019

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$50$12,27221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →